Praj Industries Ltd

Q1 FY24 Earnings Call Analysis

Industrial Manufacturing

Full Stock Analysis
fundraise: No informationcapex: Yesrevenue: Category 3margin: Category 3orderbook: Yes
💰

fundraise

Any current/future new fundraising through debt or equity?

The transcript/pages provided do not mention any current or future plans for fundraising through debt or equity by Praj Industries Limited. Key points related to finance include: - Cash in hand as on March 31st, 2024 is Rs. 7 billion (Page 4). - No specific comments or announcements were made regarding raising funds through debt or equity in the Q4 & FY24 earnings call. - Focus appears to be on business growth, order inflows, and expanding segments, rather than fundraising activities. Therefore, based on the available information, there is no indication of any ongoing or planned fundraise through debt or equity at this time.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- Praj is investing significantly in R&D for future growth, including commissioning a PLA (polylactic acid) demonstration plant expected to start operations in Q2 of the current year. - Developmental efforts focus on new bio-based molecules and multiple feedstock testing for CBG in their demo plant. - The company is expanding its business offerings with emerging segments like CBG, Sustainable Aviation Fuel (SAF), and ETCA (Engineering, Technology & Consulting Associates). - There is investment in new facilities, such as the engineering segment's ETCA facility, which has customer approvals and is expected to boost order bookings and revenue. - No specific large-scale capex numbers are disclosed, but investments are ongoing in technology development, plant commissioning, and expanding service offerings.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Praj Industries targets a 3X revenue growth by 2030, with all business segments contributing equally. - Growth drivers include strong traction in CBG (Compressed Bio Gas), ETCA, modularization, and international markets like Brazil, the US, and Africa. - Expansion expected across Bio-energy, Engineering, and PHS segments, each growing at their own potential rate. - Increasing domestic and international revenue balance targeting 50-50 by 2030. - New business avenues such as Sustainable Aviation Fuel (SAF) and bioplastics (PLA) are under development, with revenues expected in coming years. - Order book average conversion timeline is 9-12 months, with some projects extending to 18 months; strong order inflows point to growth in revenues in FY25 and FY26. - Services segment expected to grow due to recurring businesses in plant maintenance and biogenic CO2 capture.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- Praj Industries targets 3X revenue growth by 2030, with all business segments contributing equitably. - EBITDA margins aim to sustain improvements with a focus on double-digit margins, supported by higher gross margins. - Growth drivers include expansion in bioenergy (CBG, SAF, ETCA), engineering, and PHS segments. - CBG projects show viability with IRRs ranging 14%-18%, and recurring service revenues from plant maintenance and bio-solutions expected to grow. - New business avenues like PLA bioplastics and sustainable aviation fuel (SAF) are in early stages with future revenue potential. - International markets (Brazil, US, Africa) and modularization projects are significant growth areas. - R&D investments ongoing with no capitalization of related expenses, indicating near-term margin pressure but long-term growth potential. - Dividend proposal of Rs. 6 per equity share reflects strong cash position (Rs. 7 billion cash as of March 2024).
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- Order backlog as of March 2024 stands at Rs. 38,550 million. - Breakdown: 71% domestic orders; 76% from Bio-energy, 19% engineering, and 5% PHS business. - Recent quarter order intake was Rs. 9,240 million: 61% domestic, 65% Bio-energy, 30% engineering, 5% PHS. - Bio-energy segment order book shows growth with notable orders in CBG and starchy feedstock. - 600 crores order intake in Q4FY24 from Bio-energy; approx. Rs. 150 crore exports, Rs. 450 crore domestic. - Engineering order book doubled in FY24; major contribution from ETCA and modularization projects. - Order execution cycle varies with average conversion to revenue around 9 to 12 months; some large projects might extend up to 18 months. - Strong traction expected to continue in international markets. - Blue Hydrogen and other new energy projects forming part of the growing order book.